Literature DB >> 23154550

Prognostic impact of CD204-positive macrophages in lung squamous cell carcinoma: possible contribution of Cd204-positive macrophages to the tumor-promoting microenvironment.

Shunki Hirayama1, Genichiro Ishii2, Kanji Nagai3, Shotaro Ono4, Motohiro Kojima5, Chisako Yamauchi5, Keiju Aokage3, Tomoyuki Hishida3, Junji Yoshida3, Kenji Suzuki6, Atsushi Ochiai7.   

Abstract

INTRODUCTION: Tumor-associated macrophages (TAMs) are recruited into cancer-induced stroma and produce a specific microenvironment for cancer progression. CD204 (+) TAMs are reportedly related to tumor progression and clinical outcome in some tumors. The aim of this study was to clarify the correlation between CD204 (+) TAMs and the clinicopathological features of lung squamous cell carcinoma.
METHODS: We investigated the relationships between the numbers of CD204 (+) TAMs and clinicopathological factors, microvessel density, and the numbers of Foxp3 (+) lymphocytes in 208 consecutively resected cases. We also examined the relationships between the numbers of CD204 (+) TAMs and the expression levels of cytokines involved in the migration and differentiation of CD204 (+) TAMs.
RESULTS: A high number of CD204 (+) TAMs in the stroma was significantly correlated with an advanced p-stage, T factor, N factor, and the presence of vascular and pleural invasion. A high number of CD204 (+) TAMs in the stroma was also a significant prognostic factor for all p-stages and p-stage I. Moreover, the numbers of CD204 (+) TAMs were correlated with the microvessel density and the numbers of Foxp3 (+) lymphocytes. A high number of CD204 (+) TAMs was strongly correlated with the tissue expression level of monocyte chemoattractant protein-1. CD204 (+) TAMs were shown to be significant independent prognostic factors in a multivariate analysis.
CONCLUSIONS: CD204 (+) TAMs were an independent prognostic factor in lung squamous cell carcinoma. CD204 (+) TAMs, along with other tumor-promoting stromal cells such as regulatory T cells and endothelial cells, may create tumor-promoting microenvironments.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23154550     DOI: 10.1097/JTO.0b013e3182745968

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN: 1556-0864            Impact factor:   15.609


  27 in total

1.  Function of macrophage scavenger receptor 1 gene polymorphisms in chronic obstructive pulmonary disease with and without lung cancer in China.

Authors:  Liang Xie; Wei Chen; Ran Dong; Bin He; Kaishun Zhao; Li Zhang; Min Zhou; Ping He
Journal:  Oncol Lett       Date:  2018-03-21       Impact factor: 2.967

Review 2.  Macrophages and therapeutic resistance in cancer.

Authors:  Brian Ruffell; Lisa M Coussens
Journal:  Cancer Cell       Date:  2015-04-06       Impact factor: 31.743

3.  The expression of tumor-associated macrophages in papillary thyroid carcinoma.

Authors:  Bo Hyun Kim
Journal:  Endocrinol Metab (Seoul)       Date:  2013-09

4.  The association of intravascular stromal cells with prognosis in high-grade neuroendocrine carcinoma of the lung.

Authors:  Keigo Sekihara; Tomoyuki Hishida; Shinnosuke Ikemura; Koichi Saruwatari; Masahiro Morise; Takeshi Kuwata; Satoshi Fujii; Motohiro Kojima; Atsushi Ochiai; Kazuhito Funai; Keiju Aokage; Junji Yoshida; Masahiro Tsuboi; Genichiro Ishii
Journal:  J Cancer Res Clin Oncol       Date:  2015-12-22       Impact factor: 4.553

Review 5.  Clinical relevance and therapeutic aspects of professional antigen-presenting cells in lung cancer.

Authors:  Geetha Shanmugam; Sumana Das; Sambuddha Paul; Sudeshna Rakshit; Koustav Sarkar
Journal:  Med Oncol       Date:  2022-09-29       Impact factor: 3.738

Review 6.  Tumor-Associated Macrophages in Human Breast, Colorectal, Lung, Ovarian and Prostate Cancers.

Authors:  Irina Larionova; Gulnara Tuguzbaeva; Anastasia Ponomaryova; Marina Stakheyeva; Nadezhda Cherdyntseva; Valentin Pavlov; Evgeniy Choinzonov; Julia Kzhyshkowska
Journal:  Front Oncol       Date:  2020-10-22       Impact factor: 6.244

Review 7.  Scavenger Receptors: Emerging Roles in Cancer Biology and Immunology.

Authors:  Xiaofei Yu; Chunqing Guo; Paul B Fisher; John R Subjeck; Xiang-Yang Wang
Journal:  Adv Cancer Res       Date:  2015-06-17       Impact factor: 6.242

Review 8.  Myeloid immunosuppression and immune checkpoints in the tumor microenvironment.

Authors:  Kyohei Nakamura; Mark J Smyth
Journal:  Cell Mol Immunol       Date:  2019-10-14       Impact factor: 11.530

9.  Close Association of Intraepithelial Accumulation of M2-Skewed Macrophages with Neoplastic Epithelia of the Esophagus.

Authors:  Yumi Ichihara; Hiroshi Yokozaki
Journal:  Kobe J Med Sci       Date:  2021-06-18

Review 10.  Clinical significance of macrophage heterogeneity in human malignant tumors.

Authors:  Yoshihiro Komohara; Masahisa Jinushi; Motohiro Takeya
Journal:  Cancer Sci       Date:  2013-11-29       Impact factor: 6.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.